-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock

Dow Jones·04/15/2026 02:38:00

Please log in to view news